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ABSTRACT: The temperature-dependent migration of molecular
weight protein size standards and several biotherapeutic proteins
were studied in sodium dodecyl sulfate capillary gel electrophoresis
(SDS-CGE) in the interval from 15 to 60 °C using borate cross-
linked dextran sieving matrix. Arrhenius plots were generated to
calculate the respective activation energy values for the various solute
molecules. SDS-CGE analysis of the biotherapeutic protein test
mixture revealed no correlation between the activation energy
requirement of the different species and their molecular weights,
emphasizing the importance of separation temperature optimization
to obtain high resolution between the solute molecules of interest. In
contrast, the molecular weight protein size ladder ranging from 10 to
225 kDa, built from the same polypeptide blocks with no post-
translational and other modifications, showed predictable activation
energy requirement. The electrophoretic mobility of the SDS−protein complexes was found to be the function of the reciprocal sixth
root of the molecular weight (Mw
−1/6), implying cylindrical conformation.
■ INTRODUCTION
Because of recent rapid developments in the biopharmaceutical
industry, new generation therapeutic proteins have become
more and more widely available.1 With replacement of
traditional small molecule drugs with therapeutic proteins,
such as mono- or multispecific antibodies, fusion proteins,
nanobodies, etc., optimized treatment can be established
against a plethora of diseases such as hematological and solid
tumors as well as autoimmune and inflammatory ailments, just
to list a few important ones.2 Checking the purity of these
therapeutic proteins and detecting any structural ambiguities
during the manufacturing process is very important for the
biopharmaceutical field and also required by regulatory
agencies.
Sodium dodecyl sulfate capillary gel electrophoresis (SDS-
CGE) is one of the most frequently used separation techniques
for fast purity check and characterization in release and
stability studies of therapeutic proteins in the biopharmaceut-
ical industry.3 Modern capillary electrophoresis instruments
offer full automation and rapid analysis time in comparison to
manual SDS polyacrylamide slab gel electrophoresis (SDS-
PAGE), while still utilizing the same sample preparation
protocol of heat denaturation in the presence of a reducing
agent and the surfactant, resulting in the SDS micelles covering
the hydrophobic backbone of the polypeptide chain.4 Proteins
bind SDS at a 1 g per 1.4 g ratio that gives the SDS−protein
complexes approximately identical charge to mass or, more
precisely, charge to hydrodynamic volume ratio,5 requiring a
sieving matrix to obtain their size-based separation. Important
to note that, for example, glycosylation, a frequently occurring
hydrophilic post translational modification, on one hand
increases the hydrodynamic volume of the complex, but
since the hydrophilic glycan moiety does not bind SDS, the
overall charge is decreased. The effect of these two important
factors, that is, increased size and suppressed charge, decreases
the resulting electrophoretic mobility, possibly leading to
molecular mass overestimation.6,7 The resolution of the
technique is dependent on the sieving matrix composition
used and the separation conditions applied. The current
industry standard sieving matrix for SDS-CGE is borate cross-
linked dextran3,8−10 that provides excellent separation
capabilities for proteins in the molecular weight (MW) range
from 10 kDa up to a few hundred kilodaltons.
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The electrophoretic mobility (μ) of a polyion such as an SDS-








where Q is the net charge of polyion, η is the viscosity of the
separation matrix, and r is the radius of the solute molecule.
For spherical objects, Offord suggested to replace the term r by
the cubic root of the molecular weight as dimensional
equivalent or by Mw
2/3 as surface area equivalent.11 Ricard et
al. recommended the use of Mw
1/2 as radius of gyration
equivalent.13 Others suggested a rodlike cylindrical model with
the square root of Mw
1/3.14 This latter was in agreement with
the so-called “necklace” model4 of the SDS micelle covered
polypeptide chains. In addition, the repulsion effect of the
strong negative charges of the SDS molecules surrounding the
protein should also be considered to hinder folding, that is,
supporting the cylindrical model.
The viscosity of the sieving matrix is a function of the
absolute temperature (T) and can be defined by the modified
Arrhenius equation15,16
AeE RT/aη = (2)
where A is a pre-exponential factor, Ea is the activation energy,
and R is the universal gas constant. By combining eqs 1 and 2,
and summing up all the constants in constA, the electrophoretic












Therefore, under isothermal separation conditions (i.e.,
constant temperature), the μ versus 1/r plots should be linear
with temperature-dependent slopes. However, when isobaric
conditions are applied (i.e., constant MW), the logarithmic
electrophoretic mobility can be plotted as a function of the
reciprocal absolute temperature (ln μ vs 1/T), and the
activation energies for the respective molecules can be
calculated from the slopes.
Considering the above, separation temperature is an
important parameter influencing performance, which can be
optimized based on the activation energy concept to achieve
the highest resolution of the solute molecules of interest in
hand.17 In other words, since the electromigration property of
any solute molecule, including the SDS−protein complexes, is
an activated process, each and every molecule has a different
activation energy requirement to pass through the separation
matrix.17−19 The activation energy (Ea) necessary for a solute
molecule to migrate through the sieving matrix under the
applied electric field can be calculated from eq 3, as mentioned
above.
■ EXPERIMENTAL SECTION
Chemicals. In all experiments the SDS-MW Analysis Assay
kit (Sciex, Brea, CA) was used including the SDS-MW Gel
Buffer, the Sample Buffer, the 10 kDa protein standard, and the
SDS-MW Size Standard mixture (10 to 225 kDa). High-
performance liquid chromatography (HPLC) grade water and
2-mercaptoethanol was obtained from Sigma-Aldrich (St
Louis, MO). The antibody therapeutics omalizumab (Xolair)
and the nanobody (against prostate specific antigen (PSA))
were kindly provided by University of Debrecen (Debrecen,
Hungary) and University of Pannonia (Veszprem, Hungary),
respectively.
Figure 1. SDS-CGE separations of the molecular weight size standard mixture at temperatures ranging from 15 to 60 °C. Peaks: 1−10, 2−20, 3−
35, 4−50, 5−100, 6−150, 7−225 kDa. (inset) The resolution values between the peaks as the function of the separation temperature (symbols for
resolution between peaks: (gray ■) 1−2, (▲) 2−3, (gray ▲) 3−4, (●) 4−5, (■) 5−6, (gray ●) 6−7). Conditions: 20 cm effective separation
length (30 cm total), SDS-MW Gel Buffer, 20 kV applied electric potential (reversed polarity), injection: 10 kV for 20 s. Sample concentration:
1.57 mg/mL.
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Sample Preparation. The biopharma protein test mixture
was prepared by mixing 2 μL of 5 mg/mL 10 kDa protein
standard, 20 μL of 0.8 mg/mL nanobody (PSA specific), and 3
μL of 10 mg/mL omalizumab. Seventy microliters of sample
buffer (100 mM Tris-HCl, pH 9.0) containing 1% SDS and 5
μL of 2-mercaptoethanol was added to the biopharma protein
test mixture solution. The molecular weight sizing standard
was prepared by mixing 10 μL of 16 mg/mL SDS-MW Size
Standard and 2 μL of internal standard (10 kDa), diluted with
85 μL of sample buffer and the addition of 5 μL of reducing
agent (2-mercaptoethanol). The denaturation step was
accomplished by incubation in a 100 °C water bath for 3
min followed by cooling the samples to room temperature
before being used for SDS-CGE analysis.
Capillary SDS-Gel Electrophoresis. A PA800 Plus
Pharmaceutical Analysis System (Sciex) was used in UV
absorbance detection mode (214 nm) for all SDS-CGE
separations employing the SDS-MW Gel Buffer in 20 cm
effective length (30 cm total lengths), 50 μm ID bare fused
silica capillaries. The applied electric potential was 20 kV in
reversed polarity mode (cathode at the injection side). The
samples were electrokinetically injected by 10 kV for 20 s and
separated at 15, 20, 25, 30, 35, 40, 45, 50, 55, and 60 °C. The
separation temperature was controlled by the liquid-cooling
system of the instrument with ±0.1 °C precision. The
separation capillary was conditioned at the beginning of each
separation by rinsing with 0.1 M NaOH for 3 min, 0.1 M HCl
for 1 min, HPLC grade water for 5 min, and the SDS-MW gel
buffer for 5 min. All runs were made in triplicates. For data
acquisition and analysis, the 32Karat (version 10.1) software
package (Sciex) and the PeakFit (version 4.12) software were
used.
■ RESULTS AND DISCUSSION
The temperature-dependent electromigration of SDS-protein
complexes including the molecular weight size standards and a
biotherapeutic protein test mixture was studied in sodium
dodecyl sulfate capillary gel electrophoresis at the temperature
range of 15−60 °C using a borate cross-linked dextran
separation matrix.
Temperature-Dependent Electromigration of the
MW Size Standards. Figure 1 compares the SDS-CGE
separations of the protein molecular weight standard mixture
ranging from 10 to 225 kDa at capillary temperatures between
15 and 60 °C in 5 °C steps. It is important to note that the
increasing molecular weight size standards have been
assembled from the same polypeptide building blocks with
no post-translational and other modifications.20 Therefore,
they differed from each other only by the number of the
connected building blocks resulting in very similar molecular
characteristics.
Considering eq 3 at isobaric conditions, the natural
logarithms of the electrophoretic mobilities for the individual
components of the protein molecular weight size mixture were
plotted as the function of the reciprocal absolute separation
temperature between 15 and 60 °C (288−333 K) as shown in
Figure 2A (Arrhenius plots). The mobilities were adjusted with
the temperature-dependent viscosity change of the gel-buffer
system (4%/Δ5 °C).21 The activation energy values were
calculated from the slopes of the Arrhenius plots (Figure 2A)
and delineated in Figure 2B as the function of the molecular
weight of the individual protein molecules in the sample
Figure 2. (A) Arrhenius plots of the natural logarithmic electrophoretic mobility vs reciprocal absolute temperature for the protein size standard
mixture (average r2 > 0.999) under isobaric conditions. Symbols: (■) 10, (gray ■) 20, (gray ▲) 35, (×) 50, (●) 100, (gray ●) 150, (+) 225 kDa
proteins. (B) The activation energy values were derived from the slopes in (A) and plotted as the function of the molecular weight. The brackets
show the corresponding standard deviation (SD) values of triplicate runs.
Figure 3. Electrophoretic mobility values as the function of the
molecular weight of the solute molecules on the −1/6th power.
Symbols: (△) 15, (○) 20, (□) 25, (gray ▲) 30, (gray ■) 35, (+) 40,
(×) 45, (●) 50, (▲) 55 , (■) 60 °C. The r2 values of all lines were at
least 0.999.
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mixture. As one can observe, the activation energies of the
individual proteins in the molecular weight size mixture
showed convex decreasing characteristics with increasing
molecular weight in a predictable exponentially declining
function of y = 5 × 10−11x2 − 3 × 10−05x + 45.35 (r2 = 0.999).
We suggest that this well-defined change was the result of the
very similar molecular characteristics of the individual
molecular weight size standards, that is, possessing the same
polypeptide building blocks with no post-translational and
other modifications. In addition, to the predictable activation
energy requirement of the individual members of the
molecular weight size standards at different temperatures, the
resolution among the consecutive peaks in the entire size range
changed similarly (inset in Figure 1), probably also due to the
similar molecular characteristics of the sample components. It
is important to note that increasing diffusion must have also
played a role in the drop of resolution with elevating
temperatures.
In regard to the role of the activation energy requirement,
based on the groundbreaking work of the Dovichi group on a
similar phenomenon in dsDNA fragment separation,22 we
suggest that the gel matrix must have been distorted to allow
passage of the heavily charged large SDS−protein complexes.
Albeit, here we considered that the convex type decrease in the
activation energy values with increasing molecular weight may
have been influenced by the lifetime of a borate cross-linked
dextran matrix formation, which is reportedly in the low
millisecond range.9 This makes the cross-linking between the
dextran chains continuously break and reconstruct and,
concomitantly, easily restoring the sieving matrix structure
after distortion by the passing large polyions.
To better understand the migration behavior of the SDS−
protein complexes via this continuously breaking/reconstruct-
ing dextran-borate gel in narrow bore capillary columns, the
electrophoretic mobility values were plotted under isotherm
separation conditions following eq 3, using the possible Mw
Figure 4. SDS-CGE separations of a therapeutic protein test mixture at different temperatures between 15 and 60 °C. Peaks: (1) 10 kDa protein
standard, (2) nanobody (PSA specific, Mw 14.26 kDa), (3) omalizumab light chain (Mw 23.89 kDa), (4) omalizumab heavy chain (Mw 49.37 kDa).
(inset) The resolution values between the peaks as the function of the separation temperature (symbols for resolution between peaks: (■) 1−2,
(●) 2−3, (▲) 3−4). Conditions were the same as in Figure 1.
Figure 5. (A) Arrhenius plots of the natural logarithmic electrophoretic mobility vs reciprocal absolute temperature for the biotherapeutic protein
text mixture (average r2 = 0.999). Symbols: (▲)10 kDa protein, (gray ■) nanobody (14.26 kDa), (●) omalizumab light chain (23.89 kDa), (gray
×) omalizumab heavy chain (49.37 kDa). (B) The activation energy values were derived from the slopes of (A) and plotted as the function of the
molecular weight. The brackets show the corresponding SD values of triplicate runs.
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equivalents of the molecular radius. Plotting the surface
equivalents of the molecular radius suggested by Offord,11 the
average r2 values of the resulting mobility versus Mw
−1/3 and
Mw
−2/3 plots were 0.994 and 0.953, respectively, in the
temperature range examined. With the radius of gyration
approach13 using the mobility versus Mw
−1/2 plots, the
resulting average r2 value was 0.978. Finally, as Figure 3
shows, the electrophoretic mobility values of the SDS−protein
complexes were plotted as the function of the square root of
Mw
−1/3, with the assumption of possible cylindrical shapes for
the molecules (necklace model4). This approach resulted in an
average r2 value of 0.999. On the basis of this almost perfect
linear relationship, we concluded that, under isotherm
conditions, the electrophoretic mobilities of the SDS−protein
complexes were the reciprocal sixth root function of the
molecular weight (Mw
−1/6).
Therefore, we suggest the following equation to describe the
mobility of the SDS−protein complexes in borate cross-linked
dextran gels.
Q M econst E RTA w
1/6 /aμ = × × ×− − (4)
Temperature-Dependent Migration of the Biother-
apeutic Test Mixture. Figure 4 compares the temperature-
dependent separation of the 10.00 kDa protein standard, the
prostate specific antigen nanobody (14.26 kDa), as well as the
light (23.89 kDa) and heavy (49.37 kDa) chains of the
therapeutic monoclonal antibody (omalizumab).
Similar to the above, the Arrhenius plots were delineated
(Figure 5A), and the activation energy values were calculated.
Figure 5B shows the activation energy values as the function of
the molecular weights of the solute molecules. Unlike in Figure
2B, here no tendency was observed in the distribution of the
data points. These individual molecules were very different in
their polypeptide sequences and post-translational modifica-
tions, requiring very different and nonpredictable activation
energies for their electromigration through the gel matrix
emphasizing the importance of investigating the separation
temperature in SDS-SGE for separation optimization.
In contrast to the separation of the MW size standard shown
in Figure 1, the resolution between the therapeutic protein text
mixture peaks variably changed with the increasing temper-
ature, as the inset in Figure 4 depicts. The resolution between
the 10 kDa protein and the PSA specific nanobody practically
doubled with elevated temperature. The opposite happened
between the nanobody and the light chain of the antibody
therapeutics, where the resolution dropped to more than half
at 60 °C than what it was at 15 °C. The resolution between the
light and heavy chains of the monoclonal antibody drug
decreased ∼30% with elevating temperature. Please note that,
in addition to the individual activation energy requirement of
the electromigrating molecules, diffusion change mediated
band broadening must have also contributed to the resolution
change at different temperatures.
■ CONCLUSION
Sodium dodecyl sulfate capillary gel electrophoresis is a
routinely used method in the analysis of therapeutic proteins
during the process development workflow including product
characterization, stability testing, and lot release. While SDS-
CGE offers the required separation and quantification of the
light chain, heavy chain, and nonglycosylated heavy chain of
traditional monoclonal antibodies, new modality protein
pharmaceuticals are much more complex molecules than
those of conventional mAbs and, thus, may require more
sophisticated separation optimization. In this paper the effect
of separation temperature on the resolution of SDS−protein
complexes was investigated utilizing the activation energy
concept. First a molecular weight protein test mixture was
analyzed to understand the basic principles of temperature-
dependent migration of the SDS−protein complexes. The
concept was then applied to the separation of a biopharma-
ceutical protein test mixture with the goal to optimize the
separation temperature and obtain the highest resolution
between the solute molecules of interest. To shed light on the
migration behavior in SDS-CGE with borate cross-linked
dextran gels, isotherm separation conditions were utilized, and
a linear relationship was found between the electrophoretic
mobility and the Mw
−1/6 of the SDS−protein complexes
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